ATOS
Atossa Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.52
−0.40%Jun 11, 2026, 00:00 UTC
Atossa Therapeutics entered into a securities purchase agreement for a registered direct offering of 1,363,638 shares of common stock and accompanying warrants, with expected net proceeds of approximately $4.1 million.
Source: